Symbol="RETA"
AssetType="Common Stock"
Name="Reata Pharmaceuticals Inc"
Description="Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel therapies for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cell metabolism and inflammation. The company is headquartered in Plano, Texas."
CIK="1358762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="5320 LEGACY DRIVE, PLANO, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6289108000"
EBITDA="-340537984"
PERatio="None"
PEGRatio="0"
BookValue="2.306"
DividendPerShare="0"
DividendYield="0"
EPS="-9.73"
RevenuePerShareTTM="0.635"
ProfitMargin="0"
OperatingMarginTTM="-14.55"
ReturnOnAssetsTTM="-0.377"
ReturnOnEquityTTM="-1.124"
RevenueTTM="23480000"
GrossProfitTTM="-167627000"
DilutedEPSTTM="-9.73"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="28.85"
AnalystTargetPrice="172.45"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="414.73"
PriceToBookRatio="285.94"
EVToRevenue="316.34"
EVToEBITDA="-3.746"
Beta="1.437"
num_52WeekHigh="168.7"
num_52WeekLow="18.47"
num_50DayMovingAverage="115.76"
num_200DayMovingAverage="74.97"
SharesOutstanding="33036100"
DividendDate="None"
ExDividendDate="None"
symbol="RETA"
open="167.30"
high="168.02"
low="167.09"
price="167.48"
volume="348855.00"
latest_trading_day="2023-08-11"
previous_close="167.05"
change="0.43"
change_percent="0.2574%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Overbought"
value_analysis="Overvalued"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="885678"
Change_recent_avg="0.12"
Delta_recent_avg="4.02"
Variance_recent_avg="2.01"
Change_ratio_recent_avg="0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="1108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_negative_thumbnail_id_2="1109"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0142.jpeg"
image_neutral_thumbnail_id_1="537"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_neutral_thumbnail_id_2="585"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_positive_thumbnail_id_1="1008"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0170.jpeg"
image_positive_thumbnail_id_2="602"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0106.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
